ATM and interstitial lung disease: Male gender, older age, African American race, diffuse skin disease and anti-topoisomerase I antibody (ATA) positivity are reported risk factors for ILD development and progression [2] Low baseline forced vital capacity (FVC) and diffusion capacity for carbon monoxide (DLCO), CT disease extent over 20% and FVC decline of at least 10% are associated with progressive ILD [2].